Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Works matching DE "PHARMACEUTICAL industry finance"
Results: 82
1
2
INTANGIBLE ASSETS REPORTING: THE CASE OF CHEMICAL AND PHARMACEUTICAL INDUSTRY IN THE CZECH REPUBLIC.
- Published in:
- Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, 2018, v. 66, n. 2, p. 431, doi. 10.11118/actaun201866020431
- By:
- Publication type:
- Article
3
Biotech Venture Capital Investments in Public Equities and Performance.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 39, doi. 10.5912/jcb758
- By:
- Publication type:
- Article
4
Price deflation.
- Published in:
- Australian Journal of Pharmacy, 2011, v. 92, n. 1093, p. 60
- By:
- Publication type:
- Article
5
Not 'business as usual'.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
6
Surprise and no room to move on funding envelope.
- Published in:
- Australian Journal of Pharmacy, 2010, v. 91, n. 1077, p. 5
- By:
- Publication type:
- Article
7
Can pharmacy 'lump it'?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
8
Budget PBS measures attack Pharma sustainability.
- Published in:
- Australian Journal of Pharmacy, 2009, v. 90, n. 1069, p. 5
- By:
- Publication type:
- Article
9
Feared budget cuts untrue.
- Published in:
- Australian Journal of Pharmacy, 2009, v. 90, n. 1069, p. 4
- By:
- Publication type:
- Article
10
Biomedical briefing.
- Published in:
- Nature Medicine, 2014, v. 20, n. 2, p. 110, doi. 10.1038/nm0214-110
- Publication type:
- Article
11
Collaboration, cost-cutting take hold at European chemical and drug companies.
- Published in:
- Research Technology Management, 1995, v. 38, n. 4, p. 2
- By:
- Publication type:
- Article
12
Inferential Statistics as a Measure of Judging the Short-Term Solvency: An Empirical Study of Five Pharmaceutical Companies in India.
- Published in:
- IUP Journal of Accounting Research & Audit Practices, 2011, v. 10, n. 1, p. 69
- By:
- Publication type:
- Article
13
Generics and New Goods in Pharmaceutical Price Indexes: Comment.
- Published in:
- American Economic Review, 1997, v. 87, n. 4, p. 760
- By:
- Publication type:
- Article
14
Mixed US Q1 results.
- Published in:
- Chemistry & Industry, 2013, v. 77, n. 6, p. 15
- By:
- Publication type:
- Article
15
Russia seeks drug self-sufficiency.
- Published in:
- Chemistry & Industry, 2011, n. 1, p. 12
- By:
- Publication type:
- Article
16
Big pharma cuts its R&D budgets.
- Published in:
- Chemistry & Industry, 2010, n. 4, p. 5
- By:
- Publication type:
- Article
17
Playing fair.
- Published in:
- Chemistry & Industry, 2006, n. 10, p. 20
- By:
- Publication type:
- Article
18
Strong pharma and chemicals.
- Published in:
- Chemistry & Industry, 2006, n. 10, p. 4
- By:
- Publication type:
- Article
19
Stock Market Response to Regulatory Reports of Deceptive Advertising: The Moderating Effect of Omission Bias and Firm Reputation.
- Published in:
- Marketing Science, 2010, v. 29, n. 5, p. 828, doi. 10.1287/mksc.1100.0562
- By:
- Publication type:
- Article
20
What Can We Expect from Value-Based Funding of Medicines? A Retrospective Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
21
Pharmacoeconomic Evaluation in Ireland.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 4, p. 307, doi. 10.2165/11318790-000000000-00000
- By:
- Publication type:
- Article
22
Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award.
- Published in:
- 2017
- By:
- Publication type:
- journal article
23
Financing and Distribution of Pharmaceuticals in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
24
Role of Leaders in Fostering Meaningful Collaborations Between Academic Medical Centers and Industry While Also Managing Individual and Institutional Conflicts of Interest.
- Published in:
- 2017
- By:
- Publication type:
- journal article
25
Financial Conflicts of Interest in Continuing Medical Education: Implications and Accountability.
- Published in:
- 2017
- By:
- Publication type:
- journal article
26
Public Disclosure of Payments to Physicians From Industry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
27
Why There Are No "Potential" Conflicts of Interest.
- Published in:
- 2017
- By:
- Publication type:
- journal article
28
Conflict of Interest and the Integrity of the Medical Profession.
- Published in:
- 2017
- By:
- Publication type:
- journal article
29
What Do Patients Think About Physicians' Conflicts of Interest?: Watching Transparency Evolve.
- Published in:
- 2017
- By:
- Publication type:
- journal article
30
Payments to Physicians: Does the Amount of Money Make a Difference?
- Published in:
- 2017
- By:
- Publication type:
- journal article
31
Physicians, Industry Payments for Food and Beverages, and Drug Prescribing.
- Published in:
- 2017
- By:
- Publication type:
- journal article
32
Business Model-Related Conflict of Interests in Medicine: Problems and Potential Solutions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
33
Pharmaceutical payments to physicians may increase prescribing for opioids.
- Published in:
- Addiction, 2019, v. 114, n. 6, p. 1051, doi. 10.1111/add.14509
- By:
- Publication type:
- Article
34
OSNOVNI PRINCIPI FARMAKOEKONOMIJE.
- Published in:
- Medicinski Zapisi / Medical Essays, 2009, p. 7
- By:
- Publication type:
- Article
35
INCENTIVIZING THE UTILIZATION OF PHARMACOGENOMICS IN DRUG DEVELOPMENT.
- Published in:
- Journal of Health Care Law & Policy, 2012, v. 15, n. 2, p. 263
- By:
- Publication type:
- Article
36
The European pharmaceutical outlook.
- Published in:
- Nature, 1993, v. 361, n. 6414, p. 765, doi. 10.1038/361765a0
- Publication type:
- Article
37
MESC's changes bear fruits in the universities.
- Published in:
- Nature, 1993, v. 361, n. 6414, p. 761, doi. 10.1038/361761b0
- Publication type:
- Article
38
Japan's foundations still building.
- Published in:
- Nature, 1993, v. 361, n. 6414, p. 761, doi. 10.1038/361761a0
- By:
- Publication type:
- Article
39
US drug industry's research support.
- Published in:
- Nature, 1993, v. 361, n. 6414, p. 757, doi. 10.1038/361757a0
- By:
- Publication type:
- Article
40
Letter to the Editor.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
41
The Tax Cuts and Jobs Act of 2017 and the Pharmaceutical Industry.
- Published in:
- Journal of Law, Medicine & Ethics, 2018, v. 46, n. 3, p. 806, doi. 10.1177/1073110518804246
- By:
- Publication type:
- Article
42
Patient Advocacy Organizations: Institutional Conflicts of Interest, Trust, and Trustworthiness.
- Published in:
- Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 680, doi. 10.1111/jlme.12078
- By:
- Publication type:
- Article
43
From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians.
- Published in:
- Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 673, doi. 10.1111/jlme.12077
- By:
- Publication type:
- Article
44
PDUFA legislative proposals call for increased fees to help improve drug safety.
- Published in:
- Formulary, 2007, v. 42, n. 9, p. 565
- By:
- Publication type:
- Article
45
Experts Call for Urgent Action on Antibiotics Research.
- Published in:
- Applied Clinical Trials, 2015, v. 24, n. 6/7, p. 10
- By:
- Publication type:
- Article
46
\[euro]2 billion IMI launched with European pharma.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 7, p. 717, doi. 10.1038/nbt0708-717
- By:
- Publication type:
- Article
47
A better prescription for drug-development financing.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 8, p. 859, doi. 10.1038/nbt0807-859
- By:
- Publication type:
- Article
48
Prescription for an ailing pharmaceutical industry.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 4, p. 331, doi. 10.1038/nbt0402-331
- By:
- Publication type:
- Article
49
Biopharmaceutical sector performance, 1st quarter 2000.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 5, p. 476, doi. 10.1038/75255
- Publication type:
- Article
50
Determinants of Intellectual Capital Disclosure: Evidence from Indian Banking Sector.
- Published in:
- South Asian Journal of Management, 2016, v. 23, n. 1, p. 89
- By:
- Publication type:
- Article